MedTrace Logo

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

NCT05898932 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-05-13

No results posted yet for this study

Summary

The goal of this project is to use newly developed patient-reported outcomes to improve the clinical care of patients with benign prostatic hyperplasia. The use of new patient-centered tools will improve evaluation and clinical decision-making by including symptoms not commonly measured in men, such as urinary incontinence, and allow for more frequent assessment of lower urinary tract symptoms through remote surveillance. Through the use of care-coordination checklists, clinicians can be more responsive to post-treatment symptom changes, resulting in reduced bother from lower urinary tract symptoms and higher quality of life in patients with benign prostatic hyperplasia.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

OTHER

Medical Management

Participants will be managing condition with medication

OTHER

Surgical Management

Participants will be managing condition with a surgery

Sponsors & Collaborators

Principal Investigators

  • James W. Griffith, PhD · University of Chicago

  • Alexander P. Glaser, MD · NorthShore University HealthSystem, Department of Surgery, Division of Urology

  • Abigail R. Smith, PhD · Northwestern University

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05898932 on ClinicalTrials.gov